Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Change in Receivables (2021 - 2025)

Historic Change in Receivables for MDxHealth (MDXH) over the last 4 years, with Q3 2025 value amounting to $545000.0.

  • MDxHealth's Change in Receivables rose 17394.84% to $545000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$228000.0, marking a year-over-year increase of 9241.01%. This contributed to the annual value of -$3.2 million for FY2024, which is 9168.15% down from last year.
  • As of Q3 2025, MDxHealth's Change in Receivables stood at $545000.0, which was up 17394.84% from $24000.0 recorded in Q2 2025.
  • In the past 5 years, MDxHealth's Change in Receivables registered a high of $545000.0 during Q3 2025, and its lowest value of -$1.1 million during Q1 2025.
  • Over the past 4 years, MDxHealth's median Change in Receivables value was -$479000.0 (recorded in 2022), while the average stood at -$381888.9.
  • Examining YoY changes over the last 5 years, MDxHealth's Change in Receivables showed a top increase of 17394.84% in 2025 and a maximum decrease of 17394.84% in 2025.
  • Over the past 4 years, MDxHealth's Change in Receivables (Quarter) stood at -$704000.0 in 2021, then tumbled by 53.98% to -$1.1 million in 2022, then skyrocketed by 128.6% to $310000.0 in 2024, then skyrocketed by 75.81% to $545000.0 in 2025.
  • Its last three reported values are $545000.0 in Q3 2025, $24000.0 for Q2 2025, and -$1.1 million during Q1 2025.